Tag:
Horizon Therapeutics
Latest Headlines
Latest Headlines
Horizon Pharma goes public at $9
Horizon Pharma ($HZNP) went public this morning, pricing 5.5 million shares at $9 a share. That's a little below the $10 to $12 range that it had hoped for, but not too bad considering some of the
Horizon prepares to dive into chilly IPO market
Horizon Pharma will reportedly make its bid to go public this week in an effort to raise up to $66 million. The company, which develops meds for arthritis and pain, will try and offer 5.5 million
Horizon Pharma braves a chilly market with $86M IPO
Apparently undaunted by the rough reception biotech companies have received on Wall Street this year, Horizon Pharma has floated plans to raise a total of $86.25 million through an IPO. Northbrook,
Buzz: Horizon closing in on deal to buy Nitec Pharma
Bloomberg reports this morning that Horizon Therapeutics, which develops combo pain therapies, is closing in on a deal to buy Nitec Pharma AG in Switzerland. Sources tell the business news service
